Award notice · Contracts Finder
NHS National Generic Pharmaceuticals Interim 2
Part of NHS National Generic Pharmaceuticals Interim 2.
NHS National Generic Pharmaceuticals Interim 2 2020 Offer reference number: CM/PHG/20/5619 Period of framework agreement: 12 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 36 months. The total maximum duration of the framework agreement to be no more than 48 months Potential periods of call-offs under the framework agreement: Hospital only products - All regions: 01/02/2021 to 31/01/2022 Orals (plus non-parenterals) - All regions: 01/03/2021 to 28/02/2022
- Buyer
- NHS England
- Published
- 16 Feb 2021
- Status
- complete
- CPV
- 33690000 — Various medicinal products
- Tender period
- — – 5 Oct 2020
Awards
- Abbvie Ltdactive£12.3m
- Accord-UK Ltdactive£12.3m
- Altan Pharma Ltdactive£12.3m
- Amarox Limitedactive£12.3m
- Aspire Pharma Limitedactive£12.3m
- Aventis Pharma ltd t/a Sanofiactive£12.3m
- Baxter Healthcare Ltdactive£12.3m
- Bristol Laboratories Limitedactive£12.3m
- Brown & Burk UK Ltdactive£12.3m
- Cipla (EU) Ltdactive£12.3m
- Consilient Health Ltdactive£12.3m
- Crescent Pharma Ltdactive£12.3m
- CST Pharma Limitedactive£12.3m
- Drugsrus Ltdactive£12.3m
- Essential-Healthcare Ltdactive£12.3m
- Focus Pharmaceuticals Ltdactive£12.3m
- Fresenius Kabi Limitedactive£12.3m
- GlaxoSmithKline UK Limitedactive£12.3m
- Glenmark Pharmaceuticals Europe Limitedactive£12.3m
- Healthcare Pharma Ltdactive£12.3m
- HFA Healthcare Products Limitedactive£12.3m
- Kent Pharma Ltdactive£12.3m
- Laboratorio Reig Jofre SAactive£12.3m
- Lexon UK Ltdactive£12.3m
- Macleods Pharma UK Limitedactive£12.3m
- Manx Healthcare Ltdactive£12.3m
- Martindale Pharmaactive£12.3m
- medac Pharma LLPactive£12.3m
- Medley Pharma Ltdactive£12.3m
- Medreich PLCactive£12.3m
- Mercury Pharmaceuticals Limitedactive£12.3m
- Milpharm Ltd/aurobinbdoactive£12.3m
- Morningside Pharmaeuticalsactive£12.3m
- Mylanactive£12.3m
- Necessity Supplies Limitedactive£12.3m
- Panpharma UK Limitedactive£12.3m
- Pfizer Ltdactive£12.3m
- QDEM PHARMACEUTICALS LIMITEDactive£12.3m
- Ranbaxy UKactive£12.3m
- Rivopharm UK Ltdactive£12.3m
- Sandoz Ltdactive£12.3m
- Sciecure Pharma Limitedactive£12.3m
- Selective Supplies Ltd.active£12.3m
- Syri Limited (T/A Thame Laboratories)active£12.3m
- Teva UK Limitedactive£12.3m
- Thornton and Ross Ltdactive£12.3m
- Tillomed Laboratories ltdactive£12.3m
- UpJohn Limited UKactive£12.3m
- Waymade PLCactive£12.3m
- Wockhardt UK Limitedactive£12.3m
- Zentiva Pharma UK Ltdactive£12.3m
Other notices in this procurement
This is the only notice on record.
FAQs about this notice
What type of notice is this?
This is a award notice published via Contracts Finder on 16 Feb 2021.
Which procurement does this notice belong to?
It is part of "NHS National Generic Pharmaceuticals Interim 2", published by NHS England.
Has this notice resulted in an award?
51 awards are recorded on this notice, including to Abbvie Ltd.
Get the full procurement picture
Enable turns the UK's public-contract data into pipeline intelligence for bid and capture teams. Talk to us about access, alerts and tailored market analysis.
Get in touch with Enable